{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:16:08Z","timestamp":1788308168526,"version":"build-2803163510"},"reference-count":53,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2024,7,23]]},"DOI":"10.1080\/14656566.2024.2390120","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T01:14:37Z","timestamp":1722993277000},"page":"1517-1523","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis"],"prefix":"10.1080","volume":"25","author":[{"given":"Allyce","family":"Caines","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Henry Ford Health, Detroit, MI, USA"},{"name":"School of Medicine, Michigan State University, E. Lansing, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Trudeau","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Henry Ford Health, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart C.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Henry Ford Health, Detroit, MI, USA"},{"name":"School of Medicine, Wayne State University, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,11]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.10.018"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000512"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.138.10.3525"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.10.5157"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30280"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.07.004"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.029"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.003"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.023"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2619"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000708"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509840"},{"key":"e_1_3_4_15_1","unstructured":"Phase 4 study of obeticholic acid evaluating clinical outcomes in patients with primary biliary cholangitis (COBALT). Clinicaltrials.Gov identifier: nCT02308111. 2024 [cited 2024 Jul 22]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02308111"},{"key":"e_1_3_4_16_1","unstructured":"European Medicines Agency. EMA recommends revoking conditional marketing authorisation for ocaliva. 2024Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-revoking-conditional-marketing-authorisation-ocaliva"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/347645a0"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.53.082901.104018"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.039"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30246-7"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2023.100188"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1087344"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/hq1101.098228"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27744"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26018"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj20020981"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M400132-JLR200"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M027433"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3140781"},{"issue":"12","key":"e_1_3_4_30_1","first-page":"669","article-title":"Effect of clofibrate on plasma levels of alkaline phosphatase","volume":"297","author":"Zumoff B","year":"1977","unstructured":"Zumoff B. Effect of clofibrate on plasma levels of alkaline phosphatase. N Engl J Med. 1977 Sep 22;297(12):669.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13465"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.017"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26461"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.013"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306185"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1061"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1072"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwy008.204"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.02.033"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(20)33874-9"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000395"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17755"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312100"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70183-5"},{"key":"e_1_3_4_45_1","unstructured":"Administration FaD. Obeticholic acid: full prescribing information. 2021 [cited 2024 Apr 26]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/207999s007lbl.pdf"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17755"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405123301903"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90021-3"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000728"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15803"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61425-1"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.01.009"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.01.009"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21260"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2024.2390120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T02:04:24Z","timestamp":1729562664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2024.2390120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,7,23]]}},"alternative-id":["10.1080\/14656566.2024.2390120"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2024.2390120","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}